Application of the method of pharmacoencephalography for the assessment of neuroprotective drug activity
DOI:
https://doi.org/10.17072/1994-9952-2022-4-347-351Keywords:
pharmacoencephalography, neuroprotection, ratsAbstract
The search and study of new neuroprotective agents is an urgent task of biomedical research. Due to the low translational potential of the results of experimental and preclinical studies, new approaches are needed to evaluate the effectiveness of new compounds that have a positive effect on vascular or traumatic brain lesions. The method of pharmacoencephalography (pharmaco-EEG) is one of the neurophysiological research methods that allows you to assess the functional state of the brain in terms of its bioelectrical activity. Despite the need for surgical intervention, pharmaco-EEG in experimental neuroscience has several advantages over traditionally used behavioral tests, as well as biochemical or molecular genetic methods. This review considers examples of the use of this method to assess the neuroprotective activity of drugs in models of traumatic brain injury and stroke in rodents. However, based on the results of published studies, it can be concluded that pharmaco-EEG is a sensitive method for assessing the effects of drugs on the course of pathological processes in brain damage in rats and can be considered as a useful addition to traditional experimental approaches.References
Volokhova G.A., Stoyanov A.N. [Solcoseryl influence on brain trauma induced electrographic changes and behaviour in rats]. Meždunarodnyj nevrologičeskij žurnal. No 2 (2008): pp. 51-57. (In Russ.)
Gantsgorn E.V., Maklyakov Yu.S., Chloponin D.P. [Quantitative pharmaco-EEG analysis of the activity of nootropics and their combinations with melaxen in global cerebral ischemia in rats]. Biomedicina. No 3 (2015): pp. 87-94. (In Russ.)
Sysoev Yu.I., Kroshkina K.A., Okovityi S.V. [Characteristic of somatosensory evoked potentials in rats af-ter traumatic brain injury]. Rossijskij fiziologičeskij žurnal imeni I.M. Sečenova. V. 105, No 6 (2019a): pp. 749-760. (In Russ.). DOI: 10.1134/S0869813919060074.
Sysoev Yu.I. et al. [Neuroprotective activity of the alpha-2 adrenoreceptor agonist mafedine in a model of traumatic brain injury in rats]. Biomedicina. V. 15, No 1 (2019): pp. 62-77. (In Russ.). DOI: 10.33647/2074-5982-15-1-62-77.
Sysoev Yu.I. et al. [Changes in amplitude and spectral parameters of electrocorticograms in rats with traumatic brain injury]. Biomedicina. V. 15, No 4 (2019b): pp. 107-120. (In Russ.). DOI: 10.33647/2074-5982-15-4-107-120.
Sysoev Yu.I. et al. [Cross-correlation and coherence analysis of electrocorticograms of rats with traumatic brain injury]. Rossijskij fiziologičeskij žurnal imeni I.M. Sečenova. V. 106, No 3 (2020a): pp. 315-328. (In Russ.). DOI: 10.1007/s11055-020-01023-9.
Sysoev Yu.I. et al. [Changes in visual evoked potentials in rats with traumatic brain injury]. Biomedicina. V. 16, No 2 (2020b): pp. 68-77. (In Russ.). DOI: 10.33647/2074-5982-16-2-68-77.
Berger C. et al. Neuroprotection by pravastatin in acute ischemic stroke in rats. Brain Research Reviews. V. 58, No 1 (2008): pp. 48-56. DOI: 10.1016/j.brainresrev.2007.10.010.
Iino M. et al. Real-time PCR quantitation of FE65 a beta-amyloid precursor protein-binding protein after traumatic brain injury in rats. International Journal of Legal Medicine. V. 117, No 3 (2003): pp. 153-159. DOI: 10.1007/s00414-003-0370-y.
Li Y., Zhang J. Animal models of stroke. Animal Models and Experimental Medicine. V. 4, No 3 2021. P. 204–219. DOI: 10.1002/ame2.12179
Marklund N., Hillered L. Animal modeling of traumatic brain injury in preclinical drug development: where do we go from here? Brazilian Journal of Pharmacology. V. 164, No 4 (2011): pp. 1207-1229. DOI: 10.1111/j.1476-5381.2010.01163.x.
Schallert T. Behavioral tests for preclinical intervention assessment. NeuroRx. V. 3, No. 4 (2006): pp. 497-504. DOI: 10.1016/j.nurx.2006.08.001.
Sysoev Yu.I. et al. Effects of alpha-2 adrenergic agonist mafedine on brain electrical activity in rats after traumatic brain injury. Brain Sciences. V. 11, No 8 (2021): pp. 981. DOI: 10.3390/brainsci11080981.
